Efficacy and safety of a second‐generation biodegradable polymer sirolimus‐eluting stent: One‐year results of the CREDIT 2 trial

The second-generation BP-DES (EXCEL 2) was noninferior to the first-generation BP-DES (EXCEL) for the primary endpoint of in-stent LL at 9 months. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT02057978.